Skip to search formSkip to main contentSkip to account menu

carvedilol phosphate

The phosphate salt form of carvedilol, a racemic mixture and adrenergic blocking agent with antihypertensive activity and devoid of intrinsic… 
National Institutes of Health

Related topics

Related topics

20 relations
24 HR carvedilol phosphate 20 MG Extended Release Oral Capsule24 HR carvedilol phosphate 80 MG Extended Release Oral Capsule [Coreg]Adrenergic alpha-Antagonists [MoA]Angina Pectoris

Narrower (1)

Coreg

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Assessment of Once Daily Sustained Release Hydrophilic Matrix Tablet of Carvedilol
The objective of the present study was to design and evaluate once daily sustained release tablet of carvedilol, using two… 
2016
2016
Preparation method of carvedilol phosphate hemihydrate
  • 石磊
  • 2016
  • Corpus ID: 104554100
The invention provides a preparation method of carvedilol phosphate hemihydrates. The preparation method comprises the following… 
2013
2013
Formulation and Optimization of Chronotherapeutic Drug Delivery from Carvedilol Sulphate Compression Coated Tablets by using Design of Experiment Approach
Article history: The aim of this present work was to develop and optimize compression coated tablet of carvedilol sulphate for… 
2013
2013
Design and Development of Carvedilol Phosphate Floating Microsphere
2012
2012
Formulation and Evaluation of Controlled Porosity Osmotic Drug Delivery System of Carvedilol Phosphate
Controlled porosity osmotic tablet of carvedilol phosphate prepared and evaluated in this study. Carvedilol phosphate is very low… 
2012
2012
In-vitro Release Study of Carvedilol Phosphate Matrix Tablets Prepared with Hydroxypropyl Methylcellulose
Purpose: To evaluate the effect of two molecular weight grades of hydroxypropyl methylcellulose on the release characteristics of… 
2011
2011
Effective in‐vivo utilization of lipid‐based nanoparticles as drug carrier for carvedilol phosphate
Objectives  Lipid nanoparticles as carrier for oral drug administration improve gastrointestinal solubility of poorly soluble… 
2011
2011
Formulation and characterization of an expandable, gastroretentive system of carvedilol phosphate by 32 factorial design.
UNLABELLED A 3(2) full factorial design was employed for the formulation and characterization of an expandable, gastroretentive… 
2011
2011
Formulation Development and IVIVC of Controlled Porosity Osmotic Pump Tablets of Carvedilol Phosphate
Controlled porosity osmotic pump tablets loaded with carvedilol phosphate, a BCS class II drug has been successfully designed and… 
2011
2011
Novel design and synthesis of modified structure of carvedilol.
β-adrenergic blocking agents have been in use for nearly 40 years. β-blockers have been more thoroughly studied in the past… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)